StockData
Wave Life Sciences, Inc. logo

Wave Life Sciences, Inc. (WVE) stock

WVENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 10/3046% below fair value
$2.84−0.03 (-1.05%)

Close on Nov 17, 2026Market cap $560.13MP/E –Yield –

Wave Life Sciences cash

Cash and short-term investments held at the end of each period.

Wave Life Sciences's cash was $431.00M at Sep 30, 2026. For fiscal 2025 it was $602.07M, up 99.3% from the year before. Over ten years it grew 14.1% a year on average. The highest annual figure on record is $602.07M in fiscal 2025.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$602.07M+99.3%
FY2024Dec 31, 2024$302.08M+50.8%
FY2023Dec 31, 2023$200.35M+126.4%
FY2022Dec 31, 2022$88.50M-41.2%
FY2021Dec 31, 2021$150.56M-18.4%
FY2020Dec 31, 2020$184.50M+25.4%
FY2019Dec 31, 2019$147.16M-15.8%
FY2018Dec 31, 2018$174.82M+22.7%
FY2017Dec 31, 2017$142.50M-7.4%
FY2016Dec 31, 2016$153.89M-4.5%
FY2015Dec 31, 2015$161.22M+15283.6%
FY2014Dec 31, 2014$1.05M+138.7%
FY2013Dec 31, 2013$439.00K+15.8%
FY2012Dec 31, 2012$379.00K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$431.00M+119.7%
Q2 FY2026Jun 30, 2026$490.60M+135.3%
Q1 FY2026Mar 31, 2026$544.59M+124.0%
Q4 FY2025Dec 31, 2025$602.07M+99.3%
Q3 FY2025Sep 30, 2025$196.22M-36.9%
Q2 FY2025Jun 30, 2025$208.48M+35.4%
Q1 FY2025Mar 31, 2025$243.08M+34.4%
Q4 FY2024Dec 31, 2024$302.08M+50.8%
Q3 FY2024Sep 30, 2024$310.95M+122.2%
Q2 FY2024Jun 30, 2024$153.96M-11.0%
Q1 FY2024Mar 31, 2024$180.92M-12.8%
Q4 FY2023Dec 31, 2023$200.35M+126.4%
Q3 FY2023Sep 30, 2023$139.94M+14.7%
Q2 FY2023Jun 30, 2023$172.97M+16.7%
Q1 FY2023Mar 31, 2023$207.56M+85.8%
Q4 FY2022Dec 31, 2022$88.50M-41.2%
Q3 FY2022Sep 30, 2022$122.00M-1.5%
Q2 FY2022Jun 30, 2022$148.20M+3.0%
Q1 FY2022Mar 31, 2022$111.70M-24.8%
Q4 FY2021Dec 31, 2021$150.56M-18.4%
Q3 FY2021Sep 30, 2021$123.90M-42.7%
Q2 FY2021Jun 30, 2021$143.84M-33.5%
Q1 FY2021Mar 31, 2021$148.54M+22.8%
Q4 FY2020Dec 31, 2020$184.50M+25.4%
Q3 FY2020Sep 30, 2020$216.36M+3.5%
Q2 FY2020Jun 30, 2020$216.40M-14.4%
Q1 FY2020Mar 31, 2020$120.95M-57.9%
Q4 FY2019Dec 31, 2019$147.16M-15.8%
Q3 FY2019Sep 30, 2019$209.01M-0.7%
Q2 FY2019Jun 30, 2019$252.91M+4.8%
Q1 FY2019Mar 31, 2019$287.57M+160.3%
Q4 FY2018Dec 31, 2018$174.82M+22.7%
Q3 FY2018Sep 30, 2018$210.49M+24.9%
Q2 FY2018Jun 30, 2018$241.43M+22.3%
Q1 FY2018Mar 31, 2018$110.49M-17.0%
Q4 FY2017Dec 31, 2017$142.50M-7.4%
Q3 FY2017Sep 30, 2017$168.46M–
Q2 FY2017Jun 30, 2017$197.39M–
Q1 FY2017Mar 31, 2017$133.09M–
Q4 FY2016Dec 31, 2016$153.89M–

More Wave Life Sciences figures

See a number that looks wrong?